ArticleThe Journal of clinical investigation2019

In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia.

Hongjie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.